Old API Wind-down Ltd. Share Price

Stocks

ARLZQ

CA03852X1006

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Old API Wind-down Ltd. -.--% -

Valuation: Old API Wind-down Ltd.

Market Cap 87.35T 75.94T 70.68T 64.89T 1L 83.39L 1L 8L 3L 41.51L 3L 3L 1.39Cr P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 25Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 35Cr 234.38Cr 92Cr 1.17TCr 92Cr 90Cr 3.92TCr EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.53%-3.95%+50.70%+152.78% 1,02400Cr
+0.21%-2.68%+53.20%+50.87% 62TCr
-2.51%-3.25%+28.54%+67.99% 44TCr
+0.76%-1.11%+39.65%+33.40% 35TCr
-0.17%-1.73%+33.54%+41.81% 30TCr
-5.54%-7.67%+6.86%+9.17% 26TCr
+0.15%-5.99%-1.93%-42.81% 21TCr
-0.64%+2.43%+29.74%+67.16% 21TCr
-0.82%+0.70%+15.05%+72.05% 16TCr
Average -0.84%-1.21%+28.37%+50.27% 35.74TCr
Weighted average by Cap. -0.76%-2.17%+36.74%+73.11%

Financials

2016 2017
Net sales 5.43Cr 4.72Cr 4.39Cr 4.03Cr 7.61Cr 518.06Cr 7.73Cr 52Cr 20Cr 257.91Cr 20Cr 20Cr 864.83Cr 11Cr 9.21Cr 8.57Cr 7.87Cr 15Cr 1.01TCr 15Cr 101.05Cr 40Cr 503.51Cr 40Cr 39Cr 1.69TCr
Net income -10Cr -8.95Cr -8.33Cr -7.65Cr -14Cr -983.03Cr -15Cr -98Cr -39Cr -489.4Cr -39Cr -38Cr -1.64TCr -13Cr -11Cr -10Cr -9.3Cr -18Cr -1.2TCr -18Cr -119.42Cr -47Cr -595.03Cr -47Cr -46Cr -2TCr
Net Debt 21Cr 18Cr 17Cr 16Cr 29Cr 2TCr 30Cr 199.81Cr 78Cr 995.63Cr 79Cr 77Cr 3.34TCr 25Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 35Cr 234.29Cr 92Cr 1.17TCr 92Cr 90Cr 3.91TCr
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock